# Regional Erector Spinae Analgesic Block vs Standard of Care Undergoing Percutaneous Nephrolithotomy

> **NCT04663269** · PHASE4 · TERMINATED · sponsor: **Indiana University** · enrollment: 5 (actual)

## Conditions studied

- Kidney Stone
- Surgery

## Interventions

- **DRUG:** 4mg PF Dexamethasone
- **DRUG:** Control Test

## Key facts

- **NCT ID:** NCT04663269
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-24
- **Primary completion:** 2020-09-11
- **Final completion:** 2020-09-24
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Drop out from surgeons from 3 to 1. It will take too long to feasibly accrue with only one provider.
- **Last updated:** 2021-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04663269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04663269, "Regional Erector Spinae Analgesic Block vs Standard of Care Undergoing Percutaneous Nephrolithotomy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04663269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*